Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
27%
OVERLAP
BY WEIGHT
5
# OF OVERLAPPING
HOLDINGS
MEDX
28
HOLDINGS
18%
ALSO IN OZEM
OZEM
20
HOLDINGS
28%
ALSO IN MEDX
SECTOR DRIFT (MEDX minus OZEM)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in MEDX |
Weight in OZEM |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 13.9% | 15.6% | 13.9% |
|
PFIZER INC | 3.9% | 4.0% | 3.9% |
 |
ASTRAZENECA PLC-SPONS ADR | 5.4% | 3.4% | 3.4% |
|
AMGEN INC | 4.0% | 3.3% | 3.3% |
|
REGENERON PHARMACEUTICALS | 2.5% | 2.5% | 2.5% |
MEDX Overweight Relative to OZEM
|
ABBVIE INC | 9.4% |
 |
NOVARTIS AG-ADR | 7.1% |
|
ALNYLAM PHARMACEUTICALS INC | 6.6% |
|
JOHNSON & JOHNSON | 5.0% |
|
BRISTOL-MYERS SQUIBB CO | 4.7% |
 |
ALKERMES PLC | 4.0% |
|
MERCK & CO. INC. | 3.4% |
|
CRISPR THERAPEUTICS AG | 3.3% |
|
IONIS PHARMACEUTICALS, INC. | 3.1% |
|
GLAXOSMITHKLINE PLC-SPON ADR | 2.6% |
MEDX Underweight Relative to OZEM
 |
NOVO-NORDISK A/S-SPONS ADR | -19.8% |
|
ZEALAND PHARMA A/S | -6.4% |
|
ROCHE HOLDING LTD | -5.3% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -4.5% |
 |
INNOVENT BIOLOGICS, INC. | -4.4% |
 |
HANMI PHARM CO LTD | -3.0% |
|
VIKING THERAPEUTICS, INC. | -2.9% |
|
TERNS PHARMACEUTICALS, INC. | -2.8% |
|
SCHOLAR ROCK HOLDING CORP. | -2.5% |
 |
THE UNITED LABORATORIES INTE | -2.2% |